Skip to content

The Effect of Oxygen Application With Double Nasal Cannula on Respiratory Complications

The Effect of Oxygen Administration With Double Nasal Cannula on Respiratory Complications in Endoscopies

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06273319
Enrollment
200
Registered
2024-02-22
Start date
2024-03-15
Completion date
2024-06-01
Last updated
2024-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Disease, Gastric Distress

Keywords

Desaturation, oxygen therapy, Sedoanalgesia

Brief summary

To compare desaturation and respiratory complications by applying oxygen therapy with double nasal cannula to patients who are planned to undergo gastrointestinal endoscopy.

Detailed description

Two groups of patients scheduled for gastrointestinal endoscopy will be compared in terms of desaturation and respiratory complications by applying 15 litres of oxygen therapy to the first group and 30 litres to the second group with double nasal cannula.

Interventions

DRUGOXYGEN THERAPY

15 AND 30 LT OXYGEN TREATMENT

Sponsors

Inonu University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

2

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

18-65 years old PATIENTS WHO WILL HAVE ENDOSCOPY AND OR COLONOSCOPY

Exclusion criteria

* Chronic obstructive pulmonary disease Having low saturation Lung cancer

Design outcomes

Primary

MeasureTime frameDescription
Determination of the amount of oxygen to prevent the peripheral oxygen saturation of the patients from falling below 95%Up to 24 weeksDetermination of the amount of oxygen to prevent the peripheral oxygen saturation of the patients from falling below 95%

Countries

Turkey (Türkiye)

Contacts

Primary ContactDUYGU DEMIROZ, dr
drduygudemiroz@hotmail.com+905319504421

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026